Literature DB >> 17226814

Deletion of exon 16 of the dystrophin gene is not associated with disease.

Marianne Schwartz1, Morten Dunø, Anne Lise Palle, Thomas Krag, John Vissing.   

Abstract

The DNA of a male harbored a deletion of exon 16 as well as most of introns 15 and 16 of the dystrophin gene. The person was completely healthy, with universal normal muscle strength, and normal muscle histology and creatine kinase levels. The deletion was also present in DNA from a muscle biopsy, excluding mosaicism as an explanation for the phenotype. We conclude that the protein segment encoded by exon 16 of the dystrophin gene is of no importance for the essential function of dystrophin. The findings suggest that even large gene re-arrangements of the dystrophin gene may not always be disease-causing, and caution a diagnosis of dystrophinopathy in sporadic cases of single exon in-frame deletions. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226814     DOI: 10.1002/humu.9477

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  A novel noncontiguous duplication in the DMD gene escapes the 'reading-frame rule'.

Authors:  Luz Berenice López-Hernández; Benjamín Gómez-Díaz; Eliganty Bahena-Martínez; Teresa Neri-Gómez; Alejandra Camacho-Molina; Luis A Ruano-Calderón; Silvia García; Ramón M Coral-Vázquez
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

2.  Rational design of antisense oligomers to induce dystrophin exon skipping.

Authors:  Chalermchai Mitrpant; Abbie M Adams; Penny L Meloni; Francesco Muntoni; Sue Fletcher; Steve D Wilton
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

Review 3.  Optimizing exon skipping therapies for DMD.

Authors:  T Yokota; W Duddy; T Partridge
Journal:  Acta Myol       Date:  2007-12

4.  Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype.

Authors:  Nanna Witting; Morten Duno; John Vissing
Journal:  Acta Myol       Date:  2011-12

Review 5.  Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy.

Authors:  Akinori Nakamura
Journal:  J Pers Med       Date:  2019-03-04

6.  Antisense suppression of donor splice site mutations in the dystrophin gene transcript.

Authors:  Sue Fletcher; Penny L Meloni; Russell D Johnsen; Brenda L Wong; Francesco Muntoni; Stephen D Wilton
Journal:  Mol Genet Genomic Med       Date:  2013-06-13       Impact factor: 2.183

7.  Comparison of mutation profiles in the Duchenne muscular dystrophy gene among populations: implications for potential molecular therapies.

Authors:  Luz Berenice López-Hernández; Benjamín Gómez-Díaz; Alexandra Berenice Luna-Angulo; Mónica Anaya-Segura; David John Bunyan; Carolina Zúñiga-Guzman; Rosa Elena Escobar-Cedillo; Bladimir Roque-Ramírez; Luis Angel Ruano-Calderón; Héctor Rangel-Villalobos; Julia Angélica López-Hernández; Francisco Javier Estrada-Mena; Silvia García; Ramón Mauricio Coral-Vázquez
Journal:  Int J Mol Sci       Date:  2015-03-09       Impact factor: 5.923

8.  A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.

Authors:  Dunhui Li; May T Aung-Htut; Kristin A Ham; Sue Fletcher; Steve D Wilton
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

9.  Targeted exon skipping to correct exon duplications in the dystrophin gene.

Authors:  Kane L Greer; Hanns Lochmüller; Kevin Flanigan; Susan Fletcher; Steve D Wilton
Journal:  Mol Ther Nucleic Acids       Date:  2014-03-18       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.